Health News

FDA approves non-hormonal pill for menopausal hot flashes

The U.S. Food and Drug Administration (FDA) has approved a new non-hormonal pill to treat moderate to severe hot flashes, a common symptom of menopause.

Lynkuet (elinzanetant) is the first drug in a new family of drugs that directly target brain receptors responsible for temperature regulation, pharmaceutical manufacturer Bayer said in a statement. Lynkuet will be available by prescription in the United States starting next month, according to Bayer.

“Having safe and effective non-hormonal options for the treatment of bothersome hot flashes is extremely important,” says JoAnn E. Manson, MD, MPH, DrPH, professor at Harvard Medical School and chief of preventive medicine at Brigham and Women’s Hospital in Boston.

“Many women are not candidates for hormone therapy due to a history of estrogen-sensitive cancer or other medical issues, and some would simply prefer to avoid taking hormones,” says Dr. Manson. “The growing arsenal and toolbox of non-hormonal treatment options for people experiencing moderate to severe hot flashes is good news for women. »

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button